Jamjoom Pharmaceuticals Factory Company Profit Margin

Jamjoom Pharmaceuticals Factory Company posts a profit margin of 30.53% as of September 2026. That compares with 30.73% in the prior-year period — down 0.7% year over year. That is above the sector sector average of 13.23%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Jamjoom Pharmaceuticals Factory Company's profit margin was 30.73%. The latest reading is 30.53% — a 0.7% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.23% is typical. Jamjoom Pharmaceuticals Factory Company's 30.53% is higher that level. That is roughly 130.8% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Jamjoom Pharmaceuticals Factory Company's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 30.53% as of September 2026; use YoY and peer views to separate noise from signal.

Context for 4015.SR's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.23%), and (3) consistency with growth and profitability. This page covers the first two; Jamjoom Pharmaceuticals Factory Company's other metric pages and overview cover the third.